文献速递睡眠呼吸障碍

阻塞性睡眠呼吸暂停患者的夜间脑缺氧:一项随机对照试验

Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial.
PubMed 文献 · Eur Respir J · 2018-05-30

本研究纳入21例使用CPAP的OSA患者,随机分为亚治疗压CPAP组和治療压CPAP组,比较2周后夜间脑组织氧合变化。结果显示亚治疗压组脑氧饱和度下降更显著,且严重脑氧下降事件仅见于亚治疗压组,提示CPAP撤除导致夜间脑缺氧,可能参与未治疗OSA的脑损伤。

要点

  • 亚治疗压CPAP组氧减指数和脑组织氧减指数显著高于治療压组。
  • 亚治疗压组夜间平均SpO2和脑组织氧饱和度下降幅度更大。
  • 严重脑氧下降事件仅见于亚治疗压组,提示脑缺氧风险。

核心结论

  • OSA患者撤除治疗压CPAP后出现夜间脑组织氧合下降,提示脑缺氧可能参与未治疗OSA患者的脑损伤。

研究设计与样本

  • 随机对照试验,21例使用CPAP的OSA患者,平均AHI 50.3次/小时,随机接受亚治疗压或治療压CPAP 2周,比较基线至2周氧合变化。

主要发现

  • 亚治疗压组9例均出现OSA复发,治療压组12例均无复发。
  • 氧减指数组间差异:SpO2 +40.7(31.1-50.4)次/小时,脑组织氧合 +37.0(25.3-48.7)次/小时,均p<0.001。
  • 夜间平均SpO2组间差异-2.4%(-3.4至-1.1)%,脑组织氧合-3.8%(-7.4至-0.1)%,均p<0.03。
  • 严重脑组织氧下降≥13%发生于亚治疗压组4/9例,治療压组0/12例(p=0.01)。

临床怎么用

  • 治疗压CPAP可预防OSA患者夜间脑缺氧,支持对OSA进行有效CPAP治疗以降低脑缺氧相关风险。

局限性

  • 样本量小(21例),干预仅2周,未评估长期脑结构或功能结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cerebral hypoxia may promote cerebral damage in patients with obstructive sleep apnoea (OSA). We investigated whether OSA patients experience nocturnal cerebral hypoxia that is prevented by continuous positive airway pressure (CPAP).OSA patients using CPAP underwent sleep studies including pulse oximetry (arterial oxygen saturation (SpO2 )) and near-infrared spectroscopy to monitor cerebral tissue oxygenation (CTO) at baseline and after 2 weeks on either subtherapeutic or therapeutic CPAP according to randomised allocation. Changes in oxygenation at end of the 2-week intervention were compared between groups.Among 21 patients (mean apnoea/hypopnoea index 50.3 events·h-1), OSA recurred in all nine patients using subtherapeutic CPAP and in none of the patients using therapeutic CPAP: mean (95% CI) between-group differences in changes of oxygen desaturation index from baseline to 2 weeks +40.7 (31.1-50.4) events·h-1 for SpO2 and +37.0 (25.3-48.7) events·h-1 for CTO (both p<0.001). Mean nocturnal SpO2 and CTO decreased more in patients using subtherapeutic versus therapeutic CPAP: -2.4 (-3.4--1.1)% and -3.8 (-7.4--0.1)%, respectively; both p<0.03. Severe CTO drops ≥13% associated with cerebral dysfunction in previous studies occurred in four out of nine patients using subtherapeutic CPAP, but in none out of 12 patients using therapeutic CPAP (p=0.01).In patients with OSA, CPAP withdrawal resulted in nocturnal cerebral deoxygenation, suggesting a role of cerebral hypoxia in predisposing untreated OSA patients to cerebral damage.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Schwarz EI, Furian M, Schlatzer C, et al. Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial. Eur Respir J. 2018. PMID: 29700104. doi:10.1183/13993003.00032-2018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。